Oneness Biotech Statistics

Total Valuation

Oneness Biotech has a market cap or net worth of TWD 29.46 billion. The enterprise value is 23.60 billion.

Market Cap	29.46B
Enterprise Value	23.60B

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Oneness Biotech has 478.26 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	478.26M
Shares Outstanding	478.26M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-0.25%
Owned by Insiders (%)	7.94%
Owned by Institutions (%)	6.31%
Float	305.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	251.09
PB Ratio	2.44
P/TBV Ratio	2.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.11
EV / Sales	201.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-69.16

Financial Position

The company has a current ratio of 43.04, with a Debt / Equity ratio of 0.03.

Current Ratio	43.04
Quick Ratio	42.04
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-1.16
Interest Coverage	-108.07

Financial Efficiency

Return on equity (ROE) is -9.38% and return on invested capital (ROIC) is -4.68%.

Return on Equity (ROE)	-9.38%
Return on Assets (ROA)	-4.54%
Return on Invested Capital (ROIC)	-4.68%
Return on Capital Employed (ROCE)	-7.97%
Revenue Per Employee	2.73M
Profits Per Employee	-28.72M
Employee Count	43
Asset Turnover	0.01
Inventory Turnover	0.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.86% in the last 52 weeks. The beta is 1.00, so Oneness Biotech's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	-57.86%
50-Day Moving Average	66.44
200-Day Moving Average	106.54
Relative Strength Index (RSI)	48.30
Average Volume (20 Days)	1,811,116

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Oneness Biotech had revenue of TWD 117.33 million and -1.23 billion in losses. Loss per share was -2.60.

Revenue	117.33M
Gross Profit	54.02M
Operating Income	-1.02B
Pretax Income	-1.23B
Net Income	-1.23B
EBITDA	-644.38M
EBIT	-1.02B
Loss Per Share	-2.60

Full Income Statement

Balance Sheet

The company has 6.76 billion in cash and 395.96 million in debt, giving a net cash position of 6.37 billion or 13.31 per share.

Cash & Cash Equivalents	6.76B
Total Debt	395.96M
Net Cash	6.37B
Net Cash Per Share	13.31
Equity (Book Value)	12.08B
Book Value Per Share	24.24
Working Capital	6.86B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -308.71 million and capital expenditures -32.54 million, giving a free cash flow of -341.25 million.

Operating Cash Flow	-308.71M
Capital Expenditures	-32.54M
Free Cash Flow	-341.25M
FCF Per Share	-0.71

Full Cash Flow Statement

Margins

Gross Margin	46.04%
Operating Margin	-865.94%
Pretax Margin	-1,049.56%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Oneness Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.01%
Shareholder Yield	0.01%
Earnings Yield	-4.19%
FCF Yield	-1.16%

Dividend Details

Stock Splits

The last stock split was on July 26, 2024. It was a forward split with a ratio of 1.049967976.

Last Split Date	Jul 26, 2024
Split Type	Forward
Split Ratio	1.049967976

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a